Table 3 Differences between patients who have recovered from AI and those who have not
Variable | Recovered (n = 18) | Not recovered (n = 15) | P Value |
|---|---|---|---|
Age (years) | 53 ± 3.4 | 48 ± 4.8 | 0.451 |
Duration of Prednisolone use (months) | 28 ± 25.7 | 25 ± 16 | 0.888 |
Initial Prednisolone dose (milligrams) | 40 (IQR 30 to 60) | 30 (IQR 25 to 55) | 0.367 |
Index screen pre synacthen baseline cortisol 1st assay (nmol/l) | 205 ± 30 (n = 14) | 202 ± 31 (n = 9) | 0.962 |
Index screen pre synacthen baseline cortisol 2nd assay (nmol/l) | 208 ± 8.3 (n = 3) | 134 ± 30 (n = 6) | 0.148 |
Index screen post synacthen cortisol 1st assay (nmol/l) | 439 ± 25 (n = 14) | 343 ± 37 (n = 9) | 0.034 |
Index screen post synacthen cortisol 2nd assay (nmol/l) | 394 ± 24 (n = 3) | 240 ± 38 (n = 6) | 0.033 |